How Burdensome is the Diagnostic Phase ? Distress and Quality of Life in Patients Suspected of Having a (Serious) Lung Disease
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Suspected Lung Cancer
- Sponsor
- Universiteit Antwerpen
- Enrollment
- 105
- Locations
- 8
- Primary Endpoint
- longitudinal assessment of illness perception
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The purpose of this study is to gain insight in the distress experience and quality of life of patients suspected of having a serious lung disease during the diagnostic phase and the period between diagnosis and start of treatment
Detailed Description
A life-threatening disease often leads to distress, an emotional experience that can interfere with coping. Studies in lung cancer patients show high prevalence of distress during the course of the disease. However until now, very few research was done during the diagnostic workup. This prospective study will describe and explore distress, quality of life and illness perception in lung cancer patients during the diagnostic period until first follow-up visit 4 weeks after start of therapy. Patient reported questionnaires will be used.
Investigators
Kathleen Belien
Study Coordinator Thoracale Oncologie Groep Antwerpen
Universiteit Antwerpen
Eligibility Criteria
Inclusion Criteria
- •ambulatory patient
- •imaging suggestive of lung cancer
- •written informed consent
- •able to complete questionnaires
Exclusion Criteria
- •solitary pulmonary nodule
- •previous diagnosis of cancer
Outcomes
Primary Outcomes
longitudinal assessment of illness perception
Time Frame: at time of suspected lung cancer, at time of diagnosis, at time of treatment start, 4 weeks after treatment start
patient reported questionnaire (Brief-Illness Perception questionnaire)
duration of diagnostic phase and period between diagnosis and treatment start
Time Frame: date of suspected lung cancer, date communication of diagnosis, date of treatment start
longitudinal assessment of distress
Time Frame: at time of suspected lung cancer, at time of diagnosis, at time of treatment start, 4 weeks after treatment start
patient reported questionnaire (distress barometer)
longitudinal assessment of quality of life
Time Frame: at time of suspected lung cancer, at time of diagnosis, at time of treatment start, 4 weeks after treatment start
patient reported questionnaire (EORTC QLQ-C30 + lung cancer module)
Secondary Outcomes
- explore which factors are associated with distress, quality of life and illness perception(first visit suspected lung cancer, communication of diagnosis, treatment start, 4 weeks after treatment start)